Trial Profile
A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of CJ-12420 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Tegoprazan (Primary)
- Indications Erosive oesophagitis
- Focus Pharmacokinetics
- Sponsors CJ HealthCare
- 19 Dec 2016 New trial record